International Journal Of Cancer

SCI SCIE

国际简称：INT J CANCER 参考译名：国际癌症杂志

主要研究方向：医学-肿瘤学非预警期刊审稿周期：约1.5月

《国际癌症杂志》(International Journal Of Cancer)是一本由Wiley-Liss Inc.出版的以医学-肿瘤学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

2区中科院分区
Q2 JCR分区
484 年发文量
4.9 IF影响因子
未开放 是否OA
212 H-index
1966 创刊年份
Semimonthly 出版周期
Multi-Language 出版语言

The International Journal of Cancer (IJC) is the official journal of the Union for International Cancer Control—UICC; it appears twice a month. IJC invites submission of manuscripts under a broad scope of topics relevant to experimental and clinical cancer research and publishes original Research Articles and Short Reports under the following categories:

-Cancer Epidemiology-

Cancer Genetics and Epigenetics-

Infectious Causes of Cancer-

Innovative Tools and Methods-

Molecular Cancer Biology-

Tumor Immunology and Microenvironment-

Tumor Markers and Signatures-

Cancer Therapy and Prevention

[ 查看全部 ]

投稿咨询加急咨询

International Journal Of Cancer期刊信息

ISSN：0020-7136
出版语言：Multi-Language
是否OA：未开放
E-ISSN：1097-0215
出版地区：SWITZERLAND
是否预警：否
出版商：Wiley-Liss Inc.
出版周期：Semimonthly
创刊时间：1966
开源占比：0.3134
Gold OA文章占比：55.54%
OA被引用占比：0.2040...
出版国人文章占比：0.1
出版撤稿占比：0
研究类文章占比：87.19%

International Journal Of Cancer CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

9.7

1.901

1.51

学科类别	分区	排名	百分位
大类：Medicine 小类：Oncology	Q1	56 / 428	87%
大类：Medicine 小类：Cancer Research	Q1	51 / 233	78%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

International Journal Of Cancer中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	2区	ONCOLOGY 肿瘤学	2区

International Journal Of Cancer JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q2	89 / 333	73.4
学科：ONCOLOGY	SCIE	Q1	80 / 333	76.13

International Journal Of Cancer历年数据统计

影响因子

中科院分区

International Journal Of Cancer中国学者发文选摘

1、Comments on Type- and age-specific natural history of high-risk human papillomavirus infections in healthy women: A prospective cohort study in Chin
Author: Sun, Man; Jiao, Jing-Mian; Chen, Jun

Journal: INTERNATIONAL JOURNAL OF CANCER. 2026; Vol. , Issue , pp. -. DOI: 10.1002/ijc.70439
2、Reply to: Comments on Type- and age-specific natural history of high-risk human papillomavirus infections in healthy women: A prospective cohort study in Chin
Author: Quan, Jiali; Chen, Qi; Wu, Ting

Journal: INTERNATIONAL JOURNAL OF CANCER. 2026; Vol. , Issue , pp. -. DOI: 10.1002/ijc.70437
3、The 2023 FIGO staging system in uterine serous carcinoma: Exploring prognostic utility and molecular characterizatio
Author: Meng, Jiang; Ge, Li; Wang, Xiaoli; Yu, Zhicheng; Cheng, Ping; Yang, Maolin; Li, Jie; Wu, Dabao; Zhou, Ying; Zhu, Jing; Chen, Zhengzheng; Peng, Ying; Li, Yuebo; Zhao, Weidong

Journal: INTERNATIONAL JOURNAL OF CANCER. 2026; Vol. , Issue , pp. -. DOI: 10.1002/ijc.70454
4、Effect of Interval Between Neoadjuvant Immunochemotherapy and Radical Resection of Non-Small Cell Lung Cancer: A Multicenter, Retrospective Cohort Stud
Author: Wang, Jiayi; Song, Pingping; Ge, Yong; Yang, Haitang; Li, Shuyuan; Ma, Ran; Ma, Tianyue; Feng, Shoujie; Zhang, Cheng; Sun, Teng; Yao, Feng; Yi, Jun; Zhang, Hao

Journal: INTERNATIONAL JOURNAL OF CANCER. 2026; Vol. , Issue , pp. -. DOI: 10.1002/ijc.70473
5、Germline Mutation Landscape of Neuroendocrine Tumors in the Chinese Populatio
Author: Sun, Yuting; Dong, Lin; Tan, Huijing; Zhao, Dongbing; Zhao, Hong; Ying, Jianming; Chi, Yihebali

Journal: INTERNATIONAL JOURNAL OF CANCER. 2026; Vol. , Issue , pp. -. DOI: 10.1002/ijc.70482
6、The Efficacy and Safety of AI With Anlotinib Versus AI for Treating Synovial Sarcoma Patients With Lung Metastasis: A Retrospective Cohort Stud
Author: Sun, Yangbai; Liu, Xuesi; Zhu, Qinyuan; Sun, Zhengwang; Wang, Chunmeng; Yan, Wangjun

Journal: INTERNATIONAL JOURNAL OF CANCER. 2026; Vol. , Issue , pp. -. DOI: 10.1002/ijc.70501
7、Efficacy and Safety Profile of a Rituximab, Methotrexate, and Thiotepa-Based Regimen in Newly Diagnosed Primary CNS Lymphom
Author: Wang, Haotian; Li, Jia; Cao, Luming; Zhang, Ying; Wan, Xin; Wang, Xingtong; Zhao, Yangzhi; Li, Zhaoxia; Chen, Chengqian; Song, Yang; Bai, Ou

Journal: INTERNATIONAL JOURNAL OF CANCER. 2026; Vol. , Issue , pp. -. DOI: 10.1002/ijc.70507
8、Reply to: Comments on Enhanced Diagnostic Accuracy of High-Grade Cervical Intraepithelial Neoplasia in Postmenopausal Women Through PAX1/JAM3 Methylation Analysi
Author: Peng, Huanzi; Li, Jing; Zhou, Qun; Zhou, Hui; Peng, Jiaqi; Wang, Jing; Liu, Pei; He, Kun; Liu, Wene; Tan, Ping; Li, Lei; Xie, Xiaobing

Journal: INTERNATIONAL JOURNAL OF CANCER. 2026; Vol. , Issue , pp. -. DOI: 10.1002/ijc.70484